货号 |
中文名称 |
英文名词 |
靶点 |
VAPD00124 |
Research Grade Sontuzumab ( 松妥组单抗 ) Biosimilar
|
|
MUC1, MUC-1, PEM, PUM, PEMT, H23AG, EMA, CD227 |
VAPD00123 |
Research Grade Iratumumab ( 伊妥木单抗 ) Biosimilar
|
|
TNFRSF8, CD30, CD30L receptor, Ki-1 antigen |
VAPD00122 |
Research Grade Denosumab ( 地舒单抗 ) Biosimilar
|
|
TNFSF11, OPGL, ODF, RANKL, TRANCE,CD254 |
VAPD00121 |
Research Grade Panobacumab ( 帕巴库单抗 ) Biosimilar
|
|
LPS O-polysaccharide moiety |
VAPD00120 |
Research Grade Ibritumomab ( 替伊莫单抗 ) Biosimilar
|
|
MS4A1,CD20 |
VAPD00119 |
Research Grade Brentuximab ( 本妥昔单抗 ) Biosimilar
|
|
TNFRSF8, CD30,CD30L receptor, Ki-1 antigen |
VAPD00118 |
Research Grade Etaracizumab ( 埃达组单抗 ) Biosimilar
|
|
Integrin αVβ3,CD51,CD61,ITGAV, MSK8,ITGB3, GP3A |
VAPD00117 |
Research Grade Oportuzumab ( 莫妥组单抗 ) Biosimilar
|
|
EPCAM, TACSTD1, GA733-2, EGP-2, M4S1, KSA, CD326 |
VAPD00107 |
Research Grade Citatuzumab(西他组单抗 ) Biosimilar
|
|
EPCAM, TACSTD1, GA733-2, EGP-2, M4S1, KSA, CD326 |
VAPD00116 |
Research Grade Tigatuzumab ( 替加组单抗 ) Biosimilar
|
|
TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9 |